Dynamic CEA kinetics as a prognostic biomarker for HER2-negative advanced gastric cancer treated with chemoimmunotherapy. Yu S, Sun Y, Zhou J, Sun C, et al. BMC Cancer 2025;25:1857.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu S, Sun Y, Zhou J, Sun C, et al. Dynamic CEA kinetics as a prognostic biomarker for HER2-negative advanced gastric cancer treated with chemoimmunotherapy. BMC Cancer 2025;25:1857.
PMID: 41350672